AegirBio AB
AEGIR | ST
Overview
Corporate Details
- ISIN(s):
- SE0014401121 (+3 more)
- LEI:
- 549300MWGS283WZLYI10
- Country:
- Sweden
- Address:
- Scheelevägen 27, 223 63 Lund
- Website:
- https://www.aegirbio.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
AegirBio is a Swedish diagnostics company that was founded to offer tests to monitor and optimize the dosage of biological drugs via its’ unique patented technology platform. Biological drugs are the segment within the pharmaceutical industry where use is growing the fastest. Meanwhile, drug levels vary enormously (up to 100-fold) in patients receiving standard doses of biological drugs. "One size fits all" results in patients with low drug levels not responding to treatment, while excessive drug levels increase the risk of serious side effects. In approximately 55 percent of cases, this uncertainty in dosing leads to over- or underdosing, which results in unnecessary costs, inadequate results and a higher proportion of patients with severe side effects.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-04-04 | Bradley Messmer | Other | Other | 499,829 | N/A |
| 2023-01-16 | Fredrik Häglund | Other | Other | 45,244 | 85,511.16 SEK |
| 2022-12-09 | Raphaela Heussen | Other | Other | 37,689 | N/A |
| 2021-10-27 | Martin Linde | Other | Other | 370,000 | N/A |
| 2021-10-26 | Anders Ingvarsson | Other | Other | 120,000 | N/A |
| 2021-09-22 | Patrik Elfwing | Other | Buy | 2,000 | 519,200.00 SEK |
| 2021-09-16 | Anders Ingvarsson | Other | Other | 120,000 | N/A |
| 2021-06-28 | Gunnar Telhammar | Other | Sell | 460 | 47,288.00 SEK |
| 2021-06-17 | Fredrik Häglund | Other | Other | 245,397 | 1,840,477.50 SEK |
| 2021-06-17 | Martin Linde | Other | Other | 160,263 | 1,169,919.90 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cannabotech Ltd. | Israel | CNTC | |
| Canzon Israel Ltd. | Israel | CNZN | ||
|
CATALYST MEDIA GROUP PLC | United Kingdom | CMX | |
|
Celon Pharma S.A. | Poland | CLN | |
|
Chemical Works of Gedeon Richter Plc | Hungary | RICHT | |
|
COSMO Pharmaceuticals N.V. | Netherlands (Kingdom of the) | COPN | |
|
DanCann Pharma A/S | Denmark | DANCAN | |
|
DARWIN AG | Germany | 7V0 | |
|
Dechra Pharmaceuticals PLC | United Kingdom | DPH | |
|
Dermapharm Holding SE | Germany | DMP |